WebFeb 24, 2024 · Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on the progress of its near-term research and development programmes, including the expansion of its product portfolio, clinical trial activity and the publication of independent validations of the … WebJun 3, 2024 · Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the launch of two new polymerase chain reaction (PCR) assays, expanding its genesig ®...
David Allmond appointed CEO at Novacyt S.A - NewsnReleases
WebFeb 17, 2024 · Anglo-French clinical diagnostics company Novacyt also announced plans yesterday to secure an EUA for its Primerdesign coronavirus diagnostic, which detects “only the 2024 strain of the virus,” gives results in under two hours, and is thermostable, according to the press release. WebNOVACYT Daily Spotlight: Raising GDP Forecast for 1Q23 Our analysis of data that has been reported in recent weeks leads us to conclude that key parts of U.S. GDP are still expanding, despite the... shannon sharpe kelly osbourne
Novacyt S.A. (ALNOV.PA) Latest Press Releases & Corporate …
WebNovacyt (ticker: ALNOV) was listed through admission to trading of 2,389,335 existing shares and 318,127 new shares issuedunder a Global Offering. [1] The Global Offering raised a total of €2.6 million, with theadmission and issue price of shares set at €8.10 per share. Market capitalisation stood at around €22 million on the day of listing. WebMar 24, 2024 · Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Launch of CE-Mark test to detect multiple COVID-19 variants of concern SNPsig® VariPLEX™ is able to detect six key mutations of... shannon sharpe kansas city chiefs